Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8908)
All Articles published online
|
Publishing Process of This Article
|
Feb 28, 2016 (publication date) through Apr 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sui YH, Luo WJ, Xu QY, Hua J. Dietary saturated fatty acid and polyunsaturated fatty acid oppositely affect hepatic NOD-like receptor protein 3 inflammasome through regulating nuclear factor-kappa B activation. World J Gastroenterol 2016; 22(8): 2533-2544 [PMID: 26937141 DOI: 10.3748/wjg.v22.i8.2533] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i8/2533.htm |
| Number | Citing Articles |
| 1 |
Aeja Jackson, Christopher B. Forsyth, Maliha Shaikh, Robin M. Voigt, Phillip A. Engen, Vivian Ramirez, Ali Keshavarzian. Diet in Parkinson's Disease: Critical Role for the Microbiome. Frontiers in Neurology 2019; 10 doi: 10.3389/fneur.2019.01245
|
| 2 |
Rosa Lombardi, Federica Iuculano, Giada Pallini, Silvia Fargion, Anna Ludovica Fracanzani. Nutrients, Genetic Factors, and Their Interaction in Non-Alcoholic Fatty Liver Disease and Cardiovascular Disease. International Journal of Molecular Sciences 2020; 21(22): 8761 doi: 10.3390/ijms21228761
|
| 3 |
Zeinab Mokhtari, Deanna L Gibson, Azita Hekmatdoost. Nonalcoholic Fatty Liver Disease, the Gut Microbiome, and Diet. Advances in Nutrition 2017; 8(2): 240 doi: 10.3945/an.116.013151
|
| 4 |
Leen J. M. Heyens, Dana Busschots, Ger H. Koek, Geert Robaeys, Sven Francque. Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.615978
|
| 5 |
Sergio Quesada-Vázquez, Gerard Aragonès, Josep M Del Bas, Xavier Escoté. Diet, Gut Microbiota and Non-Alcoholic Fatty Liver Disease: Three Parts of the Same Axis. Cells 2020; 9(1): 176 doi: 10.3390/cells9010176
|
| 6 |
S Carbone, P J H Lee, A G Mauro, E Mezzaroma, R Buzzetti, B Van Tassell, A Abbate, S Toldo. Interleukin-18 mediates cardiac dysfunction induced by western diet independent of obesity and hyperglycemia in the mouse. Nutrition & Diabetes 2017; 7(4): e258 doi: 10.1038/nutd.2017.1
|
| 7 |
Afolarin A. Otunla, Kumaran Shanmugarajah, Alun H. Davies, Joseph Shalhoub. Lipotoxicity and immunometabolism in ischemic acute kidney injury: current perspectives and future directions. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1355674
|
| 8 |
Shaghayegh Khanmohammadi, Bruno Ramos-Molina, Mohammad Shafi Kuchay. NOD-like receptors in the pathogenesis of metabolic (dysfunction)-associated fatty liver disease: Therapeutic agents targeting NOD-like receptors. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2023; 17(7): 102788 doi: 10.1016/j.dsx.2023.102788
|
| 9 |
Marcela Cárdenas-Tueme, Larisa Montalvo-Martínez, Roger Maldonado-Ruiz, Alberto Camacho-Morales, Diana Reséndez-Pérez. Neurodegenerative Susceptibility During Maternal Nutritional Programing: Are Central and Peripheral Innate Immune Training Relevant?. Frontiers in Neuroscience 2020; 14 doi: 10.3389/fnins.2020.00013
|
| 10 |
Lisanne C Anders, Heegook Yeo, Brenna R Kaelin, Anna L Lang, Adrienne M Bushau, Amanda N Douglas, Matt Cave, Gavin E Arteel, Craig J McClain, Juliane I Beier. Role of dietary fatty acids in liver injury caused by vinyl chloride metabolites in mice. Toxicology and Applied Pharmacology 2016; 311: 34 doi: 10.1016/j.taap.2016.09.026
|
| 11 |
Salvatore Carbone, Adolfo G. Mauro, Andrea Prestamburgo, Matthew S. Halquist, Pratush Narayan, Nicola Potere, Eleonora Mezzaroma, Benjamin W. Van Tassell, Antonio Abbate, Stefano Toldo. An Orally Available NLRP3 Inflammasome Inhibitor Prevents Western Diet–Induced Cardiac Dysfunction in Mice. Journal of Cardiovascular Pharmacology 2018; 72(6): 303 doi: 10.1097/FJC.0000000000000628
|
| 12 |
Manu V. Chakravarthy, Thomas Waddell, Rajarshi Banerjee, Nicola Guess. Nutrition and Nonalcoholic Fatty Liver Disease. Gastroenterology Clinics of North America 2020; 49(1): 63 doi: 10.1016/j.gtc.2019.09.003
|
| 13 |
Giovanni Musso, Francesca Saba, Maurizio Cassader, Roberto Gambino. Lipidomics in pathogenesis, progression and treatment of nonalcoholic steatohepatitis (NASH): Recent advances. Progress in Lipid Research 2023; 91: 101238 doi: 10.1016/j.plipres.2023.101238
|
| 14 |
Kelvin Ka-Lok Wu, Samson Wing-Ming Cheung, Kenneth King-Yip Cheng. NLRP3 Inflammasome Activation in Adipose Tissues and Its Implications on Metabolic Diseases. International Journal of Molecular Sciences 2020; 21(11): 4184 doi: 10.3390/ijms21114184
|
| 15 |
Chinmayee Panda, Saradhadevi Varadharaj, Venkata Saroja Voruganti. PUFA, genotypes and risk for cardiovascular disease. Prostaglandins, Leukotrienes and Essential Fatty Acids 2022; 176: 102377 doi: 10.1016/j.plefa.2021.102377
|
| 16 |
Sisi Yan, Sha Liu, Jianyu Qu, Xiaowen Li, Jiahao Hu, Linyu Zhang, Xiangyan Liu, Xin Li, Xianglin Wang, Lixin Wen, Ji Wang. A Lard and Soybean Oil Mixture Alleviates Low-Fat–High-Carbohydrate Diet-Induced Nonalcoholic Fatty Liver Disease in Mice. Nutrients 2022; 14(3): 560 doi: 10.3390/nu14030560
|
| 17 |
Milad Moloudizargari, Fatemeh Moradkhani, Narjes Asghari, Marjan Fallah, Mohammad Hossein Asghari, Ali Akbar Moghadamnia, Mohammad Abdollahi. NLRP inflammasome as a key role player in the pathogenesis of environmental toxicants. Life Sciences 2019; 231: 116585 doi: 10.1016/j.lfs.2019.116585
|
| 18 |
Wenjing Luo, Qinyu Xu, Qi Wang, Huimin Wu, Jing Hua. Effect of modulation of PPAR-γ activity on Kupffer cells M1/M2 polarization in the development of non-alcoholic fatty liver disease. Scientific Reports 2017; 7(1) doi: 10.1038/srep44612
|
| 19 |
Ziyi Li, Fazhang Zhao, Yonggang Cao, Jingyan Zhang, Pilong Shi, Xueying Sun, Feng Zhang, Liquan Tong. DHA attenuates hepatic ischemia reperfusion injury by inhibiting pyroptosis and activating PI3K/Akt pathway. European Journal of Pharmacology 2018; 835: 1 doi: 10.1016/j.ejphar.2018.07.054
|
| 20 |
Mahmut BODUR, Reyhan NERGİZ ÜNAL. Kronik hastalıklar ekseninde diyette yüksek fruktoz ve doymuş yağ asitlerinin kronik düşük derece inflamasyon üzerine etkisi. Cukurova Medical Journal 2019; 44(2): 685 doi: 10.17826/cumj.482623
|
| 21 |
Sandra A. Soto‐Alarcón, Macarena Ortiz, Paula Orellana, Francisca Echeverría, Andrés Bustamante, Alejandra Espinosa, Paola Illesca, Daniel Gonzalez‐Mañán, Rodrigo Valenzuela, Luis A. Videla. Docosahexaenoic acid and hydroxytyrosol co‐administration fully prevents liver steatosis and related parameters in mice subjected to high‐fat diet: A molecular approach. BioFactors 2019; 45(6): 930 doi: 10.1002/biof.1556
|
| 22 |
Dan Jia, Zi Wen Li, Xinxin Zhou, Ying Gao, Yifan Feng, Min Ma, Zhengzhi Wu, Weimin Li. A novel berberine‐metformin hybrid compound exerts therapeutic effects on obese type 2 diabetic rats. Clinical and Experimental Pharmacology and Physiology 2019; 46(6): 533 doi: 10.1111/1440-1681.13085
|
| 23 |
Uğur Günşen, Ramazan Mert Atan. Role of Nutrition in Providing Pro-/Anti-Inflammatory Balance. Advances in Medical Diagnosis, Treatment, and Care 2020; : 46 doi: 10.4018/978-1-7998-3594-3.ch003
|
| 24 |
Kaine Moreno McDaid, Mridula Chopra. A Pilot Study to Examine If Dietary Habits Can Affect Symptomology in Mild Pre-Vaccination COVID-19 Cases. Biology 2022; 11(9): 1274 doi: 10.3390/biology11091274
|
| 25 |
Evanthia Tourkochristou, Christos Triantos, Athanasia Mouzaki. The Influence of Nutritional Factors on Immunological Outcomes. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.665968
|
| 26 |
Xiao-Yun Li, Pei-Xuan Ji, Xi-Xi Ni, Yu-Xin Chen, Li Sheng, Min Lian, Can-Jie Guo, Jing Hua. Regulation of PPAR-γ activity in lipid-laden hepatocytes affects macrophage polarization and inflammation in nonalcoholic fatty liver disease. World Journal of Hepatology 2022; 14(7): 1365-1381 doi: 10.4254/wjh.v14.i7.1365
|
| 27 |
Caroline C. Duwaerts, Jacquelyn J. Maher. Macronutrients and the Adipose-Liver Axis in Obesity and Fatty Liver. Cellular and Molecular Gastroenterology and Hepatology 2019; 7(4): 749 doi: 10.1016/j.jcmgh.2019.02.001
|
| 28 |
Shun Wang, Jing Zhang, Jun Chen, Lanlan Tang, Min Ke, Yanni Xue, Ying He, Yan Gong, Zhi Li. ω-3PUFAs Inhibit Hypoxia-Induced Retinal Neovascularization via Regulating Microglial Pyroptosis through METTL14-Mediated m6A Modification of IFNB1 mRNA. Applied Biochemistry and Biotechnology 2024; doi: 10.1007/s12010-023-04795-1
|
| 29 |
Xiaoxiao Wang, Huiying Rao, Feng Liu, Lai Wei, Honggui Li, Chaodong Wu. Recent Advances in Adipose Tissue Dysfunction and Its Role in the Pathogenesis of Non-Alcoholic Fatty Liver Disease. Cells 2021; 10(12): 3300 doi: 10.3390/cells10123300
|
| 30 |
Ross Arena, Jonathan Myers, Leonard A. Kaminsky, Mark Williams, Ahmad Sabbahi, Dejana Popovic, Robert Axtell, Mark A. Faghy, Andrew P. Hills, Silvia Lizett Olivares Olivares, Mildred Lopez, Nicolaas P. Pronk, Deepika Laddu, Abraham Samuel Babu, Richard Josephson, Laurie P. Whitsel, Rich Severin, Jeffrey W. Christle, Victor Zuniga Dourado, Josef Niebauer, Patrick Savage, Leslie D. Austford, Carl J Lavie. Current Activities Centered on Healthy Living and Recommendations for the Future: A Position Statement from the HL-PIVOT Network. Current Problems in Cardiology 2021; 46(6): 100823 doi: 10.1016/j.cpcardiol.2021.100823
|
| 31 |
Ross Arena, Samantha Bond, Isabel Romero Calvo, Leah Lebowicz, Cemal Ozemek, Richard Severin, Deepika Laddu, Mark A. Faghy, Carl J. Lavie, Salvatore Carbone. Shelter from the cytokine storm: Healthy living is a vital preventative strategy in the COVID-19 era. Progress in Cardiovascular Diseases 2022; 73: 56 doi: 10.1016/j.pcad.2021.06.008
|
| 32 |
Rodrigo Valenzuela, Luis A. Videla. Impact of the Co-Administration of N-3 Fatty Acids and Olive Oil Components in Preclinical Nonalcoholic Fatty Liver Disease Models: A Mechanistic View. Nutrients 2020; 12(2): 499 doi: 10.3390/nu12020499
|
| 33 |
Jeanne L. Doherty, Doreen Y. Larvie, Nitin Shivappa, James R. Hebert, Seth M. Armah. Inflammatory diets are associated with lower total iron binding capacity in sera of young adults. International Journal for Vitamin and Nutrition Research 2023; 93(1): 9 doi: 10.1024/0300-9831/a000697
|
| 34 |
Chang Guo, Lizhu chen, Jie Huang, Yuanfang Wang, Changxuan Shi, Jing Gao, Yannv Hong, Tong Chen, Longxin Qiu. Aldose reductase inhibitor protects mice from alcoholic steatosis by repressing saturated fatty acid biosynthesis. Chemico-Biological Interactions 2018; 287: 41 doi: 10.1016/j.cbi.2018.04.002
|
| 35 |
Mazhar A. Kanak, Yoshitaro Shindo, Pavithra SaiKumar, Bashoo Naziruddin. Inflammasomes: Clinical and Therapeutic Implications. Experientia Supplementum 2018; 108: 235 doi: 10.1007/978-3-319-89390-7_10
|
| 36 |
Jingjing Cai, Xiao-Jing Zhang, Hongliang Li. Role of Innate Immune Signaling in Non-Alcoholic Fatty Liver Disease. Trends in Endocrinology & Metabolism 2018; 29(10): 712 doi: 10.1016/j.tem.2018.08.003
|
| 37 |
Shu Liang, Yupei Zhang, Yuanjun Deng, Yifang He, Yinji Liang, Zien Liang, Yanning Chen, Kairui Tang, Runsen Chen, Qinhe Yang. The Potential Effect of Chinese Herbal Formula Hongqijiangzhi Fang in Improving NAFLD: Focusing on NLRP3 Inflammasome and Gut Microbiota. Evidence-Based Complementary and Alternative Medicine 2018; 2018: 1 doi: 10.1155/2018/5378961
|
| 38 |
Stavros P. Papadakos, Nikolaos Dedes, Elias Kouroumalis, Stamatios Theocharis. The Role of the NLRP3 Inflammasome in HCC Carcinogenesis and Treatment: Harnessing Innate Immunity. Cancers 2022; 14(13): 3150 doi: 10.3390/cancers14133150
|
| 39 |
Letícia Ventura, Viviane Freiberger, Vinicius B. Thiesen, Paula Dias, Matheus L. Dutra, Bruna B. Silva, Aline D. Schlindwein, Clarissa M. Comim. Involvement of NLRP3 inflammasome in schizophrenia-like behaviour in young animals after maternal immune activation. Acta Neuropsychiatrica 2020; 32(6): 321 doi: 10.1017/neu.2020.27
|
| 40 |
Maria A. Hidalgo, Marcelo Ratto, Rafael A. Burgos. Apolipoproteins, Triglycerides and Cholesterol. 2020; doi: 10.5772/intechopen.89351
|
| 41 |
Cory Iverson, Andrew Bacong, Sha Liu, Scott Baumgartner, Torbjörn Lundström, Jan Oscarsson, Jeffrey N. Miner. Omega-3-carboxylic acids provide efficacious anti-inflammatory activity in models of crystal-mediated inflammation. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-19252-x
|
| 42 |
Naren Gajenthra Kumar, Daniel Contaifer, Parthasarathy Madurantakam, Salvatore Carbone, Elvin T. Price, Benjamin Van Tassell, Donald F. Brophy, Dayanjan S. Wijesinghe. Dietary Bioactive Fatty Acids as Modulators of Immune Function: Implications on Human Health. Nutrients 2019; 11(12): 2974 doi: 10.3390/nu11122974
|
| 43 |
Hugo Charles-Messance, Kathleen A.J. Mitchelson, Elena De Marco Castro, Frederick J. Sheedy, Helen M. Roche. Regulating metabolic inflammation by nutritional modulation. Journal of Allergy and Clinical Immunology 2020; 146(4): 706 doi: 10.1016/j.jaci.2020.08.013
|
| 44 |
Sofia Kartsoli, Christina E Kostara, Vasilis Tsimihodimos, Eleni T Bairaktari, Dimitrios K Christodoulou. Lipidomics in non-alcoholic fatty liver disease. World Journal of Hepatology 2020; 12(8): 436-450 doi: 10.4254/wjh.v12.i8.436
|
| 45 |
Larisse Longo, Jéssica Tonin Ferrari, Pabulo Henrique Rampelotto, Gustavo Hirata Dellavia, Amanda Pasqualotto, Claudia P Oliveira, Carlos Thadeu Schmidt Cerski, Themis Reverbel da Silveira, Carolina Uribe-Cruz, Mário Reis Álvares-da-Silva. <p>Gut Dysbiosis and Increased Intestinal Permeability Drive microRNAs, NLRP-3 Inflammasome and Liver Fibrosis in a Nutritional Model of Non-Alcoholic Steatohepatitis in Adult Male Sprague Dawley Rats</p>. Clinical and Experimental Gastroenterology 2020; : 351 doi: 10.2147/CEG.S262879
|
| 46 |
Giovanni Musso, Maurizio Cassader, Elena Paschetta, Roberto Gambino. Bioactive Lipid Species and Metabolic Pathways in Progression and Resolution of Nonalcoholic Steatohepatitis. Gastroenterology 2018; 155(2): 282 doi: 10.1053/j.gastro.2018.06.031
|